CX-803

N/A

Report date: 2024/02/07 14:04:21

Base Information

Drug NameCX-803

Drug Alias NameCX803CX-803

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCartexell Inc

China Registration ClassN/A

Develop Information

Active CompaniesCartexell Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A